Company intelligence / Profile preview

Harbin Baolong Pharmaceutical

Harbin, Heilongjiang, China

Ownership: Private
Development stage: Other

Overview

Harbin Baolong Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based in Harbin, Heilongjiang Province, China. Established in 1994, the company specializes in the research, development, and large-scale manufacturing of chemical drugs and traditional Chinese medicines (TCM). Its product portfolio includes a wide range of dosage forms such as capsules, tablets, and injections, primarily targeting respiratory health, cardiovascular diseases, and anti-infectives. The company operates multiple GMP-certified production lines and is recognized as a key pharmaceutical manufacturer in Northeast China.

Therapeutic areas: CardiovascularImmunologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Harbin Baolong Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Harbin Baolong Pharmaceutical.

Explore the full profile